FREMONT, Calif.--(BUSINESS WIRE)--Ceterix ® Orthopaedics, Inc., a leader in the development of cutting-edge surgical tools for orthopaedic surgeons, today announced the issuance of U.S. Patent No.
Background: With advances in systemic therapy translating to improved survival in metastatic malignancies, spine metastases have become an increasingly common source of morbidity. Achieving durable ...
A rare case of IgG4-related pachymeningitis is presented. The manuscript describes the multidisciplinary treatment of a rare entity in an exceptional location, prompting emergent surgical treatment.
Evidence-based recommendations on extraurethral (non-circumferential) retropubic adjustable compression devices for stress urinary incontinence in women. This involves putting 2 small balloons on ...
Ceterix’s new patent further protects the company’s unique products and methods that allow surgeons to arthroscopically pass suture through soft tissue in very tight joint compartments. Patent Adds to ...
New Patent Further Protects the Unique Circumferential Compression Stitch Method and Expands the Company’s Intellectual Property Portfolio for Orthopaedic Applications New Patent Further Protects the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results